Alnylam

www.alnylam.com

300 Third Street
Third Floor
Cambridge
Massachusetts
02142
United States

+1 617 551 8200

Activities

R and D

Related Content

Sanofi and Alnylam enter into RNAi therapeutics rare disease alliance

New clinical data from ALN-PCSsc trial confirms potential for biannual dosing

Pipeline advancements and asset acquisitions fuelled mid-cap biotech R&D spend in 2014

Genzyme and Alnylam expand rare genetic diseases collaboration

Therapeutic nucleotides: targeting genes

Genzyme to pay Alynlam US$22.5m to develop ATTR drug in Asia

Similar Companies